I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cabozantinib in hepatocellular carcinoma: results of a phas..:
Kelley, RK
;
Verslype, C
;
Cohn, AL
...
qt0pq118gk. , 2017
Link:
https://escholarship.org/uc/item/0pq118gk
RT Journal T1
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt0pq118gk&Exemplar=1&LAN=DE A1 Kelley, RK A1 Verslype, C A1 Cohn, AL A1 Yang, T-S A1 Su, W-C A1 Burris, H A1 Braiteh, F A1 Vogelzang, N A1 Spira, A A1 Foster, P A1 Lee, Y A1 Van Cutsem, E PB eScholarship, University of California YR 2017 K1 Biomedical and Clinical Sciences K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Liver Disease K1 Clinical Trials and Supportive Activities K1 Clinical Research K1 Cancer K1 Liver Cancer K1 Digestive Diseases K1 Rare Diseases K1 Evaluation of treatments and therapeutic interventions K1 6.1 Pharmaceuticals K1 Adult K1 Aged K1 Anilides K1 Carcinoma K1 Hepatocellular K1 Disease-Free Survival K1 Double-Blind Method K1 Drug-Related Side Effects and Adverse Reactions K1 Female K1 Humans K1 Kaplan-Meier Estimate K1 Liver Neoplasms K1 Male K1 Middle Aged K1 Niacinamide K1 Phenylurea Compounds K1 Protein Kinase Inhibitors K1 Pyridines K1 Sorafenib K1 hepatocellular carcinoma K1 cabozantinib K1 vascular endothelial growth factor receptor K1 progression-free survival K1 overall survival K1 tumor response K1 Oncology & Carcinogenesis JF qt0pq118gk LK http://dx.doi.org/https://escholarship.org/uc/item/0pq118gk DO https://escholarship.org/uc/item/0pq118gk SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)